Haier J
Comprehensive Cancer Center Münster, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Deutschland,
Chirurg. 2013 Oct;84(10):892-901. doi: 10.1007/s00104-013-2607-8.
Informed consent of donors of biomaterials represents an essential pillar of legal conformity of business organizations even for biobanks. For the assessment of self-determination of donors and freedom of research for users of biobanks there is a general consensus on the necessity for a social and individual agreement for the participation of donors in research projects. However, demands are often made for which the legal implementation is at least contentious and can be considered as excessive and biased. In part 2 of this review series the current legal foundation of data protection and informed consent is summarized on the basis of normative and ethical principles. With respect to appropriation of data and biosamples it can be deduced that by conformation to corresponding framework conditions the informed consent of donors in particular can be constructed independent of the project.
生物材料捐赠者的知情同意是商业组织(即使是生物样本库)合法合规的重要支柱。对于评估捐赠者的自主决定权以及生物样本库使用者的研究自由而言,就捐赠者参与研究项目达成社会和个人协议的必要性已形成普遍共识。然而,人们常常提出一些要求,其法律实施至少存在争议,可被视为过度且有失偏颇。在本综述系列的第2部分中,基于规范和伦理原则总结了数据保护和知情同意的现行法律基础。关于数据和生物样本的获取,可以推断出,通过符合相应的框架条件,特别是捐赠者的知情同意可以独立于项目构建。